Patents by Inventor Peter Challoner

Peter Challoner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treatment of endobronchial infections
    Patent number: 8664187
    Abstract: The present invention provides methods for the treatment of an endobronchial infection in a patient by administering to the endobronchial system of the patient a dry powder aerosol composition comprising from 90 to 130 mg of an aminoglycoside antibiotic one to three times a day for a first treatment period of 20 to 36 days.
    Type: Grant
    Filed: February 24, 2012
    Date of Patent: March 4, 2014
    Assignee: Novartis AG
    Inventors: Peter Challoner, Carlos Rodriguez, Emil Samara, Thomas E Tarara, John D Lord
  • METHODS OF TREATMENT OF ENDOBRONCHIAL INFECTIONS
    Publication number: 20120148641
    Abstract: The present invention provides methods for the treatment of an endobronchial infection in a patient by administering to the endobronchial system of the patient a dry powder aerosol composition comprising from 90 to 130 mg of an aminoglycoside antibiotic one to three times a day for a first treatment period of 20 to 36 days.
    Type: Application
    Filed: February 24, 2012
    Publication date: June 14, 2012
    Inventors: Peter Challoner, Carlos Rodriguez, Emil Samara, Thomas E. Tarara, John D. Lord
  • METHODS OF TREATMENT OF ENDOBRONCHIAL INFECTIONS
    Publication number: 20110097412
    Abstract: The present invention provides methods for the treatment of an endobronchial infection in a patient by administering to the endobronchial system of the patient a dry powder aerosol composition comprising from 90 to 130 mg of an aminoglycoside antibiotic one to three times a day for a first treatment period of 20 to 36 days.
    Type: Application
    Filed: January 4, 2011
    Publication date: April 28, 2011
    Inventors: Peter Challoner, Carlos Rodriguez, Emil Samara, Thomas E. Tarara, John D. Lord
  • Methods of Treatment of Endobronchial Infections
    Publication number: 20080214481
    Abstract: The present invention provides methods for the treatment of an endobronchial infection in a patient by administering to the endobronchial system of the patient a dry powder aerosol composition comprising from 90 to 130 mg of an aminoglycoside antibiotic one to three times a day for a first treatment period of 20 to 36 days.
    Type: Application
    Filed: June 20, 2005
    Publication date: September 4, 2008
    Applicants: NOVARTIS VACCINES AND DIAGNOSTICS, INC., NEKTAR THERAPEUTICS
    Inventors: Peter Challoner, Carlos Rodriguez, Emil Samara, Thomas E. Tarara, John D. Lord
  • METHODS AND UNIT DOSE FORMULATIONS FOR THE INHALATION ADMINISTRATION OF AMINOGLYCOSIDE ANTIBIOTICS
    Publication number: 20080095717
    Abstract: A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tobramycin, in a physiologically acceptable carrier in a time period of less than about 10 minutes. Unit dose devices for storage and delivery of the aminoglycoside antibiotic formulations are also provided.
    Type: Application
    Filed: October 24, 2007
    Publication date: April 24, 2008
    Applicant: CHIRON CORPORATION
    Inventors: Robert Speirs, Barbara Schaeffler, Peter Challoner
  • Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
    Publication number: 20050207987
    Abstract: A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tobramycin, in a physiologically acceptable carrier in a time period of less than about 10 minutes. Unit dose devices for storage and delivery of the aminoglycoside antibiotic formulations are also provided.
    Type: Application
    Filed: May 10, 2005
    Publication date: September 22, 2005
    Applicant: Chiron Corporation
    Inventors: Robert Speirs, Barbara Schaeffler, Peter Challoner
  • Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
    Publication number: 20050201947
    Abstract: A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tobramycin, in a physiologically acceptable carrier in a time period of less than about 10 minutes. Unit dose devices for storage and delivery of the aminoglycoside antibiotic formulations are also provided.
    Type: Application
    Filed: May 10, 2005
    Publication date: September 15, 2005
    Applicant: Chiron Corporation
    Inventors: Robert Speirs, Barbara Schaeffler, Peter Challoner